Relationship between calcium channel blocker class and mortality in dialysis.

about

Comparative Effectiveness of Renin-Angiotensin System Antagonists in Maintenance Dialysis Patients.

P2860

Q33730477-4717B4C9-9803-4BA2-83F9-3D8C941554F1

P2860

Relationship between calcium channel blocker class and mortality in dialysis.

Item

http://www.wikidata.org/entity/Q36469666

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Relationship between calcium channel blocker class and mortality in dialysis.

@ast

Relationship between calcium channel blocker class and mortality in dialysis.

@en

type

Item

label

Relationship between calcium channel blocker class and mortality in dialysis.

@ast

Relationship between calcium channel blocker class and mortality in dialysis.

@en

prefLabel

Relationship between calcium channel blocker class and mortality in dialysis.

@ast

Relationship between calcium channel blocker class and mortality in dialysis.

@en

P1476

Relationship between calcium channel blocker class and mortality in dialysis.

@en

P2093

Edward F Ellerbeck

http://www.w3.org/2001/XMLSchema#string

James B Wetmore

http://www.w3.org/2001/XMLSchema#string

Jonathan D Mahnken

http://www.w3.org/2001/XMLSchema#string

Milind A Phadnis

http://www.w3.org/2001/XMLSchema#string

Theresa I Shireman

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Calcium channel blockers

Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis.

Self-reported and actual beta-blocker prescribing for heart failure patients: physician predictors.

Calcium-antagonist drugs.

Why general practitioners do not implement evidence: qualitative study

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

Considering health insurance: how do dialysis initiates with Medicaid coverage differ from persons without Medicaid coverage?

P304

1249-1258

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PDS.3869

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26371369

http://www.w3.org/2001/XMLSchema#string

P921

renal dialysis

P932

4715475

http://www.w3.org/2001/XMLSchema#string

Relationship between calcium channel blocker class and mortality in dialysis.

about

P2860

P2860

Relationship between calcium channel blocker class and mortality in dialysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932